Carlos Castillo-Henkel, Jorge López-Canales, María del Carmen Castillo-Hernández, Juan Asbun-Bojalil, Raul Morín-Zaragoza, Daniel Rodríguez-Choreño
Here we contrast the vascular smooth muscle contractility produced by D-nor-pseudoephedrine, alone or combined with triiodothyronine, on the aorta and coronary vasculature of the rat. At high concentrations (greater than those found in normal therapeutic dosing) D-nor-pseudoephedrine contracted the aorta. In contrast, it produced vasodilation on pre-contracted aorta independently of the vasoconstrictor employed or the presence of vascular endothelium. D-nor-pseudoephedrine increased coronary perfusion pressure, but the effect was smaller than the vasoconstriction produced by phenylephrine (a full alpha 1 adrenergic agonist), and was blocked by the pre-treatment with triiodothyronine. These results suggest cardiovascular risks in the use of D-nor-pseudoephedrine for weight loss.
{"title":"Influence of triiodothyronine on the contractile effect of D-nor-pseudoephedrine.","authors":"Carlos Castillo-Henkel, Jorge López-Canales, María del Carmen Castillo-Hernández, Juan Asbun-Bojalil, Raul Morín-Zaragoza, Daniel Rodríguez-Choreño","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Here we contrast the vascular smooth muscle contractility produced by D-nor-pseudoephedrine, alone or combined with triiodothyronine, on the aorta and coronary vasculature of the rat. At high concentrations (greater than those found in normal therapeutic dosing) D-nor-pseudoephedrine contracted the aorta. In contrast, it produced vasodilation on pre-contracted aorta independently of the vasoconstrictor employed or the presence of vascular endothelium. D-nor-pseudoephedrine increased coronary perfusion pressure, but the effect was smaller than the vasoconstriction produced by phenylephrine (a full alpha 1 adrenergic agonist), and was blocked by the pre-treatment with triiodothyronine. These results suggest cardiovascular risks in the use of D-nor-pseudoephedrine for weight loss.</p>","PeriodicalId":20701,"journal":{"name":"Proceedings of the Western Pharmacology Society","volume":"53 ","pages":"33-6"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30291423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mario I Ortiz, Xochitl Gayosso-Domínguez, Jorge Cortés-López, Georgina Romo-Hernández, Juan M López-Cadena, José A Copca-García
Chronic renal failure requiring dialysis or transplantation is known as end-stage renal disease. Several drugs are used to treating the symptoms, co-morbid conditions and treatment side effects of end-stage renal disease. We investigated drug treatment during the period of hemodialysis in children with end-stage renal disease in the Hospital del Niño DIF, Pachuca, Hidalgo, Mexico. Data were collected from hospital records. The data included demographic, clinical data and those on drug usage. A total of 13 patients were included. The average age of patients was 14.2 +/- 2.1 years. Eighteen different medications were administered; the mean number of drugs during the period of hemodialysis was 1.3 +/- 0.6 (range 1-4). Two-hundred sixteen doses of medication were administered in 130 hemodialysis sessions. The drugs most used were erythropoietin (42.7 %), followed by dextrose solution (18.9 %), calcium gluconate (10.4 %), iron dextran (9.1%) and nifedipine (5.5 %). Medications may be used to help control some of the issues associated with kidney failure or hemodialysis. Our study showed that few drugs are administered to children with ESRD during their period of hemodialysis.
{"title":"Medication use during hemodialysis in children with end-stage renal disease in a Mexican pediatric hospital.","authors":"Mario I Ortiz, Xochitl Gayosso-Domínguez, Jorge Cortés-López, Georgina Romo-Hernández, Juan M López-Cadena, José A Copca-García","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Chronic renal failure requiring dialysis or transplantation is known as end-stage renal disease. Several drugs are used to treating the symptoms, co-morbid conditions and treatment side effects of end-stage renal disease. We investigated drug treatment during the period of hemodialysis in children with end-stage renal disease in the Hospital del Niño DIF, Pachuca, Hidalgo, Mexico. Data were collected from hospital records. The data included demographic, clinical data and those on drug usage. A total of 13 patients were included. The average age of patients was 14.2 +/- 2.1 years. Eighteen different medications were administered; the mean number of drugs during the period of hemodialysis was 1.3 +/- 0.6 (range 1-4). Two-hundred sixteen doses of medication were administered in 130 hemodialysis sessions. The drugs most used were erythropoietin (42.7 %), followed by dextrose solution (18.9 %), calcium gluconate (10.4 %), iron dextran (9.1%) and nifedipine (5.5 %). Medications may be used to help control some of the issues associated with kidney failure or hemodialysis. Our study showed that few drugs are administered to children with ESRD during their period of hemodialysis.</p>","PeriodicalId":20701,"journal":{"name":"Proceedings of the Western Pharmacology Society","volume":"53 ","pages":"42-3"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30291426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Maria del Carmen Castillo-Hernandez, Noemi Meraz-Cruz, Gustavo Guevara-Balcazar, Jorge Lopez-Canales, Oscar Lopez-Canales, Norma Galindo, Carlos Castillo-Henkel
Mechanisms underlying age-dependent changes in vasodilator responses to beta-adrenergic drugs are poorly understood. The aim of the current study was to compare responses to isoproterenol (a non-selective beta-adrenergic receptor agonist) in phenylephrine or KCl precontracted aortic rings from 3 week and 3 month old male Wistar rats. Both the mechanism and the subtype of beta-adrenergic receptor underlying the response to isoproterenol in the both age groups were examined. Endothelial removal, pre-contraction with KCl (40 mM), pre-treatment with tetraethylammonium or with N(omega)-Nitro-L-arginine methyl ester inhibited the vasodilator response to isoproterenol only in aortic rings from older rats. The inhibition was total when TEA and L-NAME were administered together. In both age groups the response to isoproterenol was unaffected by the beta1-adrenergic antagonist CGP20712A, but was significantly inhibited by ICI 118551 (a beta2-adrenergic-antagonist) and to a greater extent by SR 59230A (a non-selective beta 3-adrenergic antagonist), the inhibition being more evident in the older rats. Unlike younger rats, in older animals the response to isoproterenol was partially dependent on endothelial nitric oxide and on K+ channels. In both age groups, beta2- and beta3-, but not beta1-adrenergic receptors were involved. The degree of relative participation of beta2 and beta3 adrenergic receptors may change with age and explain the differences in response to isoproterenol.
{"title":"Age-related differences in the beta-adrenergic vasodilator response in rat aortic rings.","authors":"Maria del Carmen Castillo-Hernandez, Noemi Meraz-Cruz, Gustavo Guevara-Balcazar, Jorge Lopez-Canales, Oscar Lopez-Canales, Norma Galindo, Carlos Castillo-Henkel","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Mechanisms underlying age-dependent changes in vasodilator responses to beta-adrenergic drugs are poorly understood. The aim of the current study was to compare responses to isoproterenol (a non-selective beta-adrenergic receptor agonist) in phenylephrine or KCl precontracted aortic rings from 3 week and 3 month old male Wistar rats. Both the mechanism and the subtype of beta-adrenergic receptor underlying the response to isoproterenol in the both age groups were examined. Endothelial removal, pre-contraction with KCl (40 mM), pre-treatment with tetraethylammonium or with N(omega)-Nitro-L-arginine methyl ester inhibited the vasodilator response to isoproterenol only in aortic rings from older rats. The inhibition was total when TEA and L-NAME were administered together. In both age groups the response to isoproterenol was unaffected by the beta1-adrenergic antagonist CGP20712A, but was significantly inhibited by ICI 118551 (a beta2-adrenergic-antagonist) and to a greater extent by SR 59230A (a non-selective beta 3-adrenergic antagonist), the inhibition being more evident in the older rats. Unlike younger rats, in older animals the response to isoproterenol was partially dependent on endothelial nitric oxide and on K+ channels. In both age groups, beta2- and beta3-, but not beta1-adrenergic receptors were involved. The degree of relative participation of beta2 and beta3 adrenergic receptors may change with age and explain the differences in response to isoproterenol.</p>","PeriodicalId":20701,"journal":{"name":"Proceedings of the Western Pharmacology Society","volume":"53 ","pages":"29-32"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30292041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
David Calderón Guzmán, Norma Labra Ruiz, Ernestina Hernández García, Hugo Juárez Olguín
We analyzed the effect of marijuana and nalbuphine on levels of 5-hydroxyindol acetic acid and lipid peroxidation in rat brain. Single and repeated dosages of 250 mg/kg marijuana extract or 10 mg/kg nalbuphine were administered to male and female Wistar rats. Animals were sacrificed and brains were obtained to measure the content of 5-hydroxyindol acetic acid, reduced glutathione, thiobarbituric acid reactive substances, total ATPase and Na+/K+ ATPase activities. There was an increase in thiobarbituric acid reactive substances, total ATPase and Na+/K+ ATPase activity in the animals that received a single dose of marijuana and nalbuphine (p=0.001), with a notable decrease in glutathione and 5-hydroxyindol acetic acid levels (p=0.001). Both marijuana and nalbuphine increased levels of oxidative damage biomarkers in rat brain and decreased glutathione and 5-hydroxyindol acetic acid levels which could provoke changes in cellular and biochemical regulations and serotonergic activity in either male or female rats.
{"title":"Levels of 5-hydroxyindol acetic acid and lipid peroxidation in brain after administration of marijuana and nalbuphine in male and female rat.","authors":"David Calderón Guzmán, Norma Labra Ruiz, Ernestina Hernández García, Hugo Juárez Olguín","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>We analyzed the effect of marijuana and nalbuphine on levels of 5-hydroxyindol acetic acid and lipid peroxidation in rat brain. Single and repeated dosages of 250 mg/kg marijuana extract or 10 mg/kg nalbuphine were administered to male and female Wistar rats. Animals were sacrificed and brains were obtained to measure the content of 5-hydroxyindol acetic acid, reduced glutathione, thiobarbituric acid reactive substances, total ATPase and Na+/K+ ATPase activities. There was an increase in thiobarbituric acid reactive substances, total ATPase and Na+/K+ ATPase activity in the animals that received a single dose of marijuana and nalbuphine (p=0.001), with a notable decrease in glutathione and 5-hydroxyindol acetic acid levels (p=0.001). Both marijuana and nalbuphine increased levels of oxidative damage biomarkers in rat brain and decreased glutathione and 5-hydroxyindol acetic acid levels which could provoke changes in cellular and biochemical regulations and serotonergic activity in either male or female rats.</p>","PeriodicalId":20701,"journal":{"name":"Proceedings of the Western Pharmacology Society","volume":"53 ","pages":"20-5"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30292039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mario I Ortiz, Héctor A Ponce-Monter, Eduardo Fernández-Martínez, Arturo Macías, Eduardo Rangel-Flores, Jeannett A Izquierdo-Vega, Manuel Sánchez-Gutiérrez
There is evidence that local peripheral administration of gabapentin produces antinociception through the activation of the ATP-sensitive K+-channel. However, this interaction has not been evaluated systemically, nor in diabetic rat. This work was undertaken to determine whether glibenclamide has any effect on the systemic antinociception induced by gabapentin. Inflammatory pain was induced by injection of formalin in diabetic rats. Reduction of flinching behavior was considered as antinociception. Systemic administration of gabapentin (10-56 mg/kg, i.p.) produced a dose-dependent antinociception in both phases of the formalin test. Also, glibenclamide (1-10 mg/kg, s.c.) blocked the gabapentin-induced antinociception. Given alone glibenclamide did not significantly modify formalin-induced nociception in diabetic rats. Our data suggest that gabapentin is able to reduce formalin-induced nociception in streptozotocin-injected rats. In addition, these data are consistent with gabapentin-mediated activation of ATP-sensitive-K+ channels to produce systemic antinociception in the formalin test in diabetic rats.
有证据表明,局部外周给药加巴喷丁通过激活atp敏感的K+通道产生抗痛觉。然而,这种相互作用还没有被系统地评估,也没有在糖尿病大鼠中评估。这项工作是为了确定格列本脲是否对加巴喷丁诱导的全身抗伤性有任何影响。采用注射福尔马林诱导糖尿病大鼠炎症性疼痛。减少退缩行为被认为是抗感觉。全身给药加巴喷丁(10-56 mg/kg, i.p)在福尔马林试验的两个阶段都产生剂量依赖性的抗痛觉作用。格列本脲(1 ~ 10mg /kg, s.c)阻断加巴喷丁诱导的抗痛觉作用。单给格列苯脲对糖尿病大鼠福尔马林引起的伤害感觉无明显改善作用。我们的数据表明,加巴喷丁能够减少福尔马林诱导的链脲佐菌素注射大鼠的伤害感受。此外,在糖尿病大鼠的福尔马林试验中,这些数据与加巴喷丁介导的atp敏感- k +通道激活产生全身抗伤感受一致。
{"title":"Pharmacological interaction between gabapentin and glibenclamide in the formalin test in the diabetic rat.","authors":"Mario I Ortiz, Héctor A Ponce-Monter, Eduardo Fernández-Martínez, Arturo Macías, Eduardo Rangel-Flores, Jeannett A Izquierdo-Vega, Manuel Sánchez-Gutiérrez","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>There is evidence that local peripheral administration of gabapentin produces antinociception through the activation of the ATP-sensitive K+-channel. However, this interaction has not been evaluated systemically, nor in diabetic rat. This work was undertaken to determine whether glibenclamide has any effect on the systemic antinociception induced by gabapentin. Inflammatory pain was induced by injection of formalin in diabetic rats. Reduction of flinching behavior was considered as antinociception. Systemic administration of gabapentin (10-56 mg/kg, i.p.) produced a dose-dependent antinociception in both phases of the formalin test. Also, glibenclamide (1-10 mg/kg, s.c.) blocked the gabapentin-induced antinociception. Given alone glibenclamide did not significantly modify formalin-induced nociception in diabetic rats. Our data suggest that gabapentin is able to reduce formalin-induced nociception in streptozotocin-injected rats. In addition, these data are consistent with gabapentin-mediated activation of ATP-sensitive-K+ channels to produce systemic antinociception in the formalin test in diabetic rats.</p>","PeriodicalId":20701,"journal":{"name":"Proceedings of the Western Pharmacology Society","volume":"53 ","pages":"49-51"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30291429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rodolfo Velasco-Lezama, Antonio Muñoz Torres, Rafaela Tapia Aguilar, José Luis Flores Saenz, Martha Fregoso Padilla, Elisa Vega Avila, Eduardo Barrera Escorcia
Smilax aristolochiaefolia (Liliaceae) has been used in Mexican traditional medicine for the treatment of tumors, leprosy, anemia and as a tonic for skin infections and anemia. Aplastic anemia (AA) was induced in CD1 mice 8-12 weeks old distributed 10 animals each in Groups VSC, AA, AASa and AAr. Groups AA, AASa and AAr received benzene (2 ml/kg diluted v/v with corn oil) subcutaneously every three days until 20 dosages had been administered. The vehicular solution control group (VSC) received corn oil and the HC group (healthy control) received saline solution. Two days after the last benzene inoculation, groups AA and HC were bled and sacrificed to count blood and bone marrow cells. Group AASa received an aqueous S. aristolochiaefolia (0.4 g/kg) solution orally on days 3, 5 and 7 after the last dosage of benzene, meanwhile group AAr received no treatment after induction of AA (self recovery). On day 9 these groups were bled and sacrificed to count blood and bone marrow cells. Mice with aplastic anemia treated with S. aristolochiaefolia extract, recovered normal platelet levels and nucleated bone marrow cells as compared with the control, but the counts of erythrocytes and leukocyte were lower than controls (p<0.005). The aqueous extract of S. aristolochiaefolia (zarzaparrilla) restores hematopoeisis in the bone marrow of mice with aplastic anemia.
{"title":"Hematopoietic activity of Smilax aristolochiaefolia (zarzaparrilla) in mice with aplastic anemia.","authors":"Rodolfo Velasco-Lezama, Antonio Muñoz Torres, Rafaela Tapia Aguilar, José Luis Flores Saenz, Martha Fregoso Padilla, Elisa Vega Avila, Eduardo Barrera Escorcia","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Smilax aristolochiaefolia (Liliaceae) has been used in Mexican traditional medicine for the treatment of tumors, leprosy, anemia and as a tonic for skin infections and anemia. Aplastic anemia (AA) was induced in CD1 mice 8-12 weeks old distributed 10 animals each in Groups VSC, AA, AASa and AAr. Groups AA, AASa and AAr received benzene (2 ml/kg diluted v/v with corn oil) subcutaneously every three days until 20 dosages had been administered. The vehicular solution control group (VSC) received corn oil and the HC group (healthy control) received saline solution. Two days after the last benzene inoculation, groups AA and HC were bled and sacrificed to count blood and bone marrow cells. Group AASa received an aqueous S. aristolochiaefolia (0.4 g/kg) solution orally on days 3, 5 and 7 after the last dosage of benzene, meanwhile group AAr received no treatment after induction of AA (self recovery). On day 9 these groups were bled and sacrificed to count blood and bone marrow cells. Mice with aplastic anemia treated with S. aristolochiaefolia extract, recovered normal platelet levels and nucleated bone marrow cells as compared with the control, but the counts of erythrocytes and leukocyte were lower than controls (p<0.005). The aqueous extract of S. aristolochiaefolia (zarzaparrilla) restores hematopoeisis in the bone marrow of mice with aplastic anemia.</p>","PeriodicalId":20701,"journal":{"name":"Proceedings of the Western Pharmacology Society","volume":"52 ","pages":"83-7"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30290581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
María Cristina Márquez-Orozco, Irma Zarco de Coronado, Amalia Márquez-Orozco, Graciela de la Fuente-Juárez, María Verónica Gazca-Ramírez, Ignacio Méndez-Ramírez
The response of adult female mice to diazepam (DZ) can be sculpted by the prenatal experience with the drug. Experiments were performed in ICR strain (Harlan México) mice exposed in utero to DZ. They were born from dams injected (s.c.) with 2.7 mg/kg/bw of DZ or just saline solution from day 6 to 17 of pregnancy. They were maintained at 12:12 dark/light cycles with food and water ad libitum. On the experimental day, mice were introduced in an activity meter (actometer) for 5 min. Recordings were run at 25 mm/min. The time they remained motionless or clearly sleepy was determined in millimeters. After that, all animals received (s.c.) 2.7 mg/kg/bw of DZ; 15 min later they were introduced into the actometer again for 5 min. Before DZ, control animals injected with saline during gestation showed 1.57 +/- 0.53 mm and the experimental (DZ) prenatally exposed to DZ, 3.69 +/- 1.72 mm (p =0.27). After DZ, control animals remained motionless for 37.27 +/- 6.77 mm and DZ mice, 59.95 +/- 7.10 mm (p=0.03). This result indicates a significantly larger response to DZ in the pretreated animals, suggesting that exposure of the developing fetus to the drug may lead to persistent (14 months) morphological alterations in several areas of the central nervous system with physiological repercussion on motor behavior and learning, sometimes attributed to brain circuitry modifications or to the developmental vulnerability of synaptic neurochemical mechanisms.
成年雌性小鼠对地西泮(DZ)的反应可以通过产前用药经历来塑造。实验是在子宫内暴露于DZ的ICR系(Harlan m xico)小鼠中进行的。在妊娠第6天至第17天,它们从注射2.7 mg/kg/bw DZ或仅注射生理盐水的母鼠中出生。它们被维持在12:12的暗/光循环,并随意提供食物和水。实验当天,将小鼠置于活动计(actometer)中5 min,以25 mm/min的速度进行记录。他们保持静止或明显困倦的时间以毫米为单位。之后,所有动物接受(s.c) 2.7 mg/kg/bw的DZ;15 min后再次进入测压仪5 min。DZ前,对照组妊娠期注射生理盐水为1.57 +/- 0.53 mm,实验组妊娠期注射生理盐水为3.69 +/- 1.72 mm (p =0.27)。DZ后,对照组小鼠静止时间为37.27 +/- 6.77 mm, DZ小鼠静止时间为59.95 +/- 7.10 mm (p=0.03)。这一结果表明,经预处理的动物对DZ的反应明显更大,表明发育中的胎儿暴露于DZ可能导致中枢神经系统几个区域的持续(14个月)形态学改变,对运动行为和学习产生生理影响,有时归因于脑回路改变或突触神经化学机制的发育脆弱性。
{"title":"Motor response of 14-month-old female mice exposed to diazepam prenatally.","authors":"María Cristina Márquez-Orozco, Irma Zarco de Coronado, Amalia Márquez-Orozco, Graciela de la Fuente-Juárez, María Verónica Gazca-Ramírez, Ignacio Méndez-Ramírez","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The response of adult female mice to diazepam (DZ) can be sculpted by the prenatal experience with the drug. Experiments were performed in ICR strain (Harlan México) mice exposed in utero to DZ. They were born from dams injected (s.c.) with 2.7 mg/kg/bw of DZ or just saline solution from day 6 to 17 of pregnancy. They were maintained at 12:12 dark/light cycles with food and water ad libitum. On the experimental day, mice were introduced in an activity meter (actometer) for 5 min. Recordings were run at 25 mm/min. The time they remained motionless or clearly sleepy was determined in millimeters. After that, all animals received (s.c.) 2.7 mg/kg/bw of DZ; 15 min later they were introduced into the actometer again for 5 min. Before DZ, control animals injected with saline during gestation showed 1.57 +/- 0.53 mm and the experimental (DZ) prenatally exposed to DZ, 3.69 +/- 1.72 mm (p =0.27). After DZ, control animals remained motionless for 37.27 +/- 6.77 mm and DZ mice, 59.95 +/- 7.10 mm (p=0.03). This result indicates a significantly larger response to DZ in the pretreated animals, suggesting that exposure of the developing fetus to the drug may lead to persistent (14 months) morphological alterations in several areas of the central nervous system with physiological repercussion on motor behavior and learning, sometimes attributed to brain circuitry modifications or to the developmental vulnerability of synaptic neurochemical mechanisms.</p>","PeriodicalId":20701,"journal":{"name":"Proceedings of the Western Pharmacology Society","volume":"52 ","pages":"105-8"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30291093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Eusebio Contreras, José Antonio Rojas-Ramírez, Consuelo Izazola-Conde, Héctor Javier Delgadillo-Gutiérrez, Yolanda Saldaña-Balmori, Claudi Barbarella Contreras-de la Parra, Nicandro Mendoza-Patiño, Ignacio Méndez-Ramírez
In higher education, learning variables are critical for professional activity and they should be properly assessed. Therefore, adequacy of evaluation instruments is very important. Consistency of an exam is one characteristic frequently studied to determine exam reliability. The subject of this study is a Pharmacology test of 70 items, taken by 849 medical students during a Pharmacology course at Medical School in the National University of Mexico in 2008. It explores whether students have been exposed to the same knowledge domain and if consistent execution in all parts of the exam is seen. Exam items were analyzed as independent items and as grouped items (by topic) and tested for consistency with Cronbach's test. Data were processed with the JMP statistical program (SAS Institute Inc.). The coefficient alpha was greater for independent items. We consider that grouping of items into topics tests integration of knowledge; a reasonable degree of consistency found when items are grouped, might favor this conclusion. Information obtained from the analysis of consistency of the exam, should provide elements for feedback during a course. Long term goals of this study include: to develop test instruments useful in formative evaluation and knowledge integration, to characterize the specificity of a Pharmacology exam, to determine degrees of knowledge acquisition and to get feedback about the quality of courses and exams.
在高等教育中,学习变量对专业活动至关重要,应该对其进行适当的评估。因此,评估工具的充分性是非常重要的。考试的一致性是确定考试可靠性的一个经常被研究的特征。本研究以2008年墨西哥国立大学医学院药理学课程849名医学生参加的70项药理学测试为研究对象。它探讨了学生是否接触了相同的知识领域,以及是否在考试的所有部分都看到了一致的执行。测试项目分别作为独立项目和分组项目(按主题)进行分析,并与Cronbach测试进行一致性测试。数据采用JMP统计程序(SAS Institute Inc.)处理。独立项目的alpha系数更大。我们认为题目分组可以测试知识的整合性;当项目被分组时,发现一个合理的一致性程度,可能有利于这个结论。从考试一致性分析中获得的信息,应在课程中提供反馈的要素。本研究的长期目标包括:开发有助于形成性评估和知识整合的测试工具,表征药理学考试的特殊性,确定知识获取程度,并获得有关课程和考试质量的反馈。
{"title":"Testing a test: Analysis of the consistency of a pharmacology exam.","authors":"Eusebio Contreras, José Antonio Rojas-Ramírez, Consuelo Izazola-Conde, Héctor Javier Delgadillo-Gutiérrez, Yolanda Saldaña-Balmori, Claudi Barbarella Contreras-de la Parra, Nicandro Mendoza-Patiño, Ignacio Méndez-Ramírez","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In higher education, learning variables are critical for professional activity and they should be properly assessed. Therefore, adequacy of evaluation instruments is very important. Consistency of an exam is one characteristic frequently studied to determine exam reliability. The subject of this study is a Pharmacology test of 70 items, taken by 849 medical students during a Pharmacology course at Medical School in the National University of Mexico in 2008. It explores whether students have been exposed to the same knowledge domain and if consistent execution in all parts of the exam is seen. Exam items were analyzed as independent items and as grouped items (by topic) and tested for consistency with Cronbach's test. Data were processed with the JMP statistical program (SAS Institute Inc.). The coefficient alpha was greater for independent items. We consider that grouping of items into topics tests integration of knowledge; a reasonable degree of consistency found when items are grouped, might favor this conclusion. Information obtained from the analysis of consistency of the exam, should provide elements for feedback during a course. Long term goals of this study include: to develop test instruments useful in formative evaluation and knowledge integration, to characterize the specificity of a Pharmacology exam, to determine degrees of knowledge acquisition and to get feedback about the quality of courses and exams.</p>","PeriodicalId":20701,"journal":{"name":"Proceedings of the Western Pharmacology Society","volume":"52 ","pages":"115-7"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30291096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Paul G Stumpf, Emily Stumpf, Britta Anderson, Jay Schulkin
The rate of improvement in patient safety is slow. The goal of this review is to address the results of a survey of Ob-Gyn physicians regarding important patient safety issues. A sample of 600 obstetricians and gynecologists were sent a survey asking them about their beliefs, activities, problems, and source of information regarding patient safety with a response rate of 53.2%. Results about beliefs and patient safety activities have been reported [Stumpf et al., 2009]. Misdiagnosis (95.6%), failure to follow-up with patients (94.9%), and administration of the wrong medication or dosage of a medication (90.5%) were the most often reported patient safety problems. Obstetricians and gynecologists most often use printed materials, CMEs, journals, and practice guidelines for information regarding patient safety. Ob-Gyns prefer to learn new patient safety information using printed materials and post graduate classes rather than materials on compact disk or online webcasts. A majority of respondents recognize patient safety as an important issue. Education about the importance of patient safety may be a less pertinent topic when compared to the need for education about implementing specific tools for patient safety and moving from awareness to action.
病人安全的改善速度很慢。本综述的目的是针对一项关于重要患者安全问题的妇产科医生调查的结果。对600名妇产科医生进行调查,询问他们对患者安全的看法、活动、问题和信息来源,回复率为53.2%。关于信念和患者安全活动的结果已被报道[Stumpf et al., 2009]。误诊(95.6%)、未与患者随访(94.9%)和给药或用药剂量错误(90.5%)是最常见的患者安全问题。妇产科医生通常使用印刷材料、cme、期刊和实践指南来获取有关患者安全的信息。妇产科医生更喜欢通过印刷材料和研究生课程来学习新的患者安全信息,而不是通过光盘或在线网络广播来学习。大多数应答者认为患者安全是一个重要问题。与实施特定的患者安全工具以及从意识到行动的教育需求相比,关于患者安全重要性的教育可能是一个不太相关的主题。
{"title":"A review of patient safety in women's healthcare: why has our progress been so slow?","authors":"Paul G Stumpf, Emily Stumpf, Britta Anderson, Jay Schulkin","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The rate of improvement in patient safety is slow. The goal of this review is to address the results of a survey of Ob-Gyn physicians regarding important patient safety issues. A sample of 600 obstetricians and gynecologists were sent a survey asking them about their beliefs, activities, problems, and source of information regarding patient safety with a response rate of 53.2%. Results about beliefs and patient safety activities have been reported [Stumpf et al., 2009]. Misdiagnosis (95.6%), failure to follow-up with patients (94.9%), and administration of the wrong medication or dosage of a medication (90.5%) were the most often reported patient safety problems. Obstetricians and gynecologists most often use printed materials, CMEs, journals, and practice guidelines for information regarding patient safety. Ob-Gyns prefer to learn new patient safety information using printed materials and post graduate classes rather than materials on compact disk or online webcasts. A majority of respondents recognize patient safety as an important issue. Education about the importance of patient safety may be a less pertinent topic when compared to the need for education about implementing specific tools for patient safety and moving from awareness to action.</p>","PeriodicalId":20701,"journal":{"name":"Proceedings of the Western Pharmacology Society","volume":"52 ","pages":"1-4"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30146801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Taurine and the neurotransmitter GABA are both inhibitory in nature in the brain. The effects of GABA receptor agonists and antagonists on taurine release were studied in hippocampal slices prepared from developing 7-day-old and young adult 3-month-old mice. In ischemia no significant effects were discernible, but in normoxia the agonists of all three classes of GABA receptors enhanced the basal release of taurine among mice of both ages. The K+-evoked release was potentiated only in adults. The effects were receptor-mediated, being blocked by GABA receptor antagonists. Taurine may thus augment GABAergic inhibition in this brain region.
{"title":"Agonists and antagonists of GABA receptors modify taurine release in the mouse hippocampus in normoxia, but not in ischemia.","authors":"Simo S Oja, Pirjo Saransaari","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Taurine and the neurotransmitter GABA are both inhibitory in nature in the brain. The effects of GABA receptor agonists and antagonists on taurine release were studied in hippocampal slices prepared from developing 7-day-old and young adult 3-month-old mice. In ischemia no significant effects were discernible, but in normoxia the agonists of all three classes of GABA receptors enhanced the basal release of taurine among mice of both ages. The K+-evoked release was potentiated only in adults. The effects were receptor-mediated, being blocked by GABA receptor antagonists. Taurine may thus augment GABAergic inhibition in this brain region.</p>","PeriodicalId":20701,"journal":{"name":"Proceedings of the Western Pharmacology Society","volume":"52 ","pages":"129-31"},"PeriodicalIF":0.0,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30292035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}